STAT3 and neoplasm: Dihydroartemisinin-dependent inhibition of STAT3 decreased the levels of antiapoptotic (Bcl-xL, Mcl-1), proproliferative (cyclin D1), prometastatic (MMP-2/9) and proangiogenic (VEGF) proteins resulting in inhibited xenograft tumor growth (85).